Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
  1. SC 13D Stake Beneficial Ownership Report
  2. SC 13D Stake Beneficial Ownership Report
  3. 4 Grant or award Chief Executive Officer acquired 2,707,059 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Director acquired 1,760,337 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 13,583 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 8-K Event Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change
  16. 8-K Event Shareholder vote results
  17. 10-Q Report Quarterly Report
  18. DEFA14A Proxy Proxy Materials
  19. 8-K Event Results of operations
  20. DEFM14A Deal DEFM14A

Page 22 of 38 · 753 filings